Palmoplantar Psoriasis: Epidemiological and Clinical Features and Impact on Quality of Life

Introduction: Palmoplantar psoriasis is a rare variant of psoriasis. Its impact on quality of life have been poorly investigated. Objectives: Our aim was to investigate the prevalence of localized palmoplantar psoriasis (PPP), to assess its severity using the modified-Palmoplantar Pustular Psoriasis...

Full description

Saved in:
Bibliographic Details
Main Authors: Dorsaf Elinkichari (Author), Faten Rabhi (Author), Kahena Jaber (Author), Raouf Dhaoui (Author)
Format: Book
Published: Mattioli1885, 2024-07-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_017dd9907e204e96a45df8acf006a7b5
042 |a dc 
100 1 0 |a Dorsaf Elinkichari  |e author 
700 1 0 |a Faten Rabhi  |e author 
700 1 0 |a Kahena Jaber  |e author 
700 1 0 |a Raouf Dhaoui  |e author 
245 0 0 |a Palmoplantar Psoriasis: Epidemiological and Clinical Features and Impact on Quality of Life 
260 |b Mattioli1885,   |c 2024-07-01T00:00:00Z. 
500 |a 10.5826/dpc.1403a191 
500 |a 2160-9381 
520 |a Introduction: Palmoplantar psoriasis is a rare variant of psoriasis. Its impact on quality of life have been poorly investigated. Objectives: Our aim was to investigate the prevalence of localized palmoplantar psoriasis (PPP), to assess its severity using the modified-Palmoplantar Pustular Psoriasis Area and Severity Index (m-PPPASI), and to evaluate the correlation with the Dermatology Life Quality Index (DLQI). Methods: We conducted a descriptive study with prospective data-collection from January to June 2021. We enrolled 223 patients with psoriasis. We excluded patients without palmar/plantar involvement, and those with a body surface area (BSA) greater than or equal to 10%. Results: We included 33 patients with PPP. This corresponded to a 14.8% prevalence among all psoriasis phenotypes. The mean age was 45 years. The male to female ratio was 2.3. Pruritus was present in 27 cases. The mean m-PPPASI was 11.77. The mean DLQI was 8.33. A significant correlation was found between DLQI and m-PPPASI: Mean DLQI scores for patients with m-PPPASI less than or equal to 10 and m-PPPASI greater than 10 were 5.6 and 11.3, respectively (p=0.002). Only 11.8% of patients with m-PPPASI less than or equal to 10 had a DLQI greater than 10, whereas 50% of those with m-PPPASI greater than 10 had a DLQI greater than 10 (p=0.026). Conclusions: Based on the present work, we confirm that, although affecting a reduced BSA, PPP is a severe form of psoriasis. We consider the m-PPPASI to be a reliable tool which can be used to assess the severity of PPP. 
546 |a EN 
690 |a Psoriasis 
690 |a Palmoplantar Psoriasis 
690 |a Keratoderma 
690 |a Quality of life 
690 |a Dermatology 
690 |a RL1-803 
655 7 |a article  |2 local 
786 0 |n Dermatology Practical & Conceptual, Vol 14, Iss 3 (2024) 
787 0 |n https://dpcj.org/index.php/dpc/article/view/2754 
787 0 |n https://doaj.org/toc/2160-9381 
856 4 1 |u https://doaj.org/article/017dd9907e204e96a45df8acf006a7b5  |z Connect to this object online.